Dr. Mary Ella Kenefake, MD

Dr. Kenefake practices at Presence St. Francis Hospital- Evanston in Evanston, Illinois.

Dr. Kenefake's NPI, 1548421498, was assigned on June 23, 2008. Dr. Kenefake holds Illinois license 036132755.

Dr. Kenefake's primary practice is Presence St. Francis Hospital- Evanston, at 355 Ridge Ave, Evanston, IL 60202 in Cook County. The practice phone is (847) 316-4000.

Dr. Kenefake's primary practice is Presence St. Francis Hospital- Evanston in Evanston, Illinois. Dr. Kenefake is also affiliated with Saint Francis Hospital - Evanston. The medical group on file is CEP America. Dmand AI also links Dr. Kenefake to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kenefake practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Kenefake's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Kenefake's licenses on file in 2 states: Illinois and Indiana.

CMS data shows 799 Medicare services from Dr. Kenefake across 5 procedure codes in 2024, for 558 Medicare patients. Medicare paid $82,188 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 558 Medicare patients who saw Dr. Kenefake in 2024. The largest group is 75 to 84, with 177 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kenefake's median patient age at 56, with 50% women.

In 2024, Dr. Kenefake wrote 85 Medicare Part D claims for 64 patients. 91% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $200 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kenefake for performance year 2024, reported as part of a group. Dr. Kenefake accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Kenefake from 2 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $12.